Related Experiment Videos
Repression of bleomycin-induced pneumopathy by TNF
Misuzu Kuroki1, Yuji Noguchi, Michihide Shimono
1Second Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan.
Journal of Immunology (Baltimore, Md. : 1950)
|December 24, 2002
Summary
Tumor necrosis factor (TNF) plays a crucial role in lung inflammation. This study reveals TNF is essential for repressing pulmonary inflammation in bleomycin-induced lung injury, contrary to prior beliefs.
Area of Science:
- Pulmonary Medicine
- Immunology
- Toxicology
Background:
- Idiopathic pulmonary fibrosis is a chronic inflammatory lung disease.
- Tumor necrosis factor (TNF) is a pro-inflammatory cytokine implicated in lung disease pathogenesis.
- Previous studies suggest TNF has both pro- and anti-inflammatory roles.
Purpose of the Study:
- To investigate the role of TNF in bleomycin-induced pulmonary inflammation.
- To determine if TNF deficiency exacerbates or ameliorates lung injury.
- To elucidate the mechanism of TNF's action in bleomycin-induced pneumopathy.
Main Methods:
- Intratracheal bleomycin instillation in TNF-deficient and wild-type mice.
- Assessment of inflammatory cell apoptosis and infiltration.
- Evaluation of bronchoalveolar lavage fluid and lung histology.
Main Results:
- TNF-deficient mice exhibited persistent, intense pulmonary inflammation.
- Reduced apoptosis of inflammatory cells was observed in TNF-deficient mice.
- Murine TNF administration promoted inflammatory cell apoptosis and lung repair in deficient mice.
Conclusions:
- TNF is essential for repressing pulmonary inflammation in bleomycin-induced pneumopathy.
- TNF promotes the apoptosis of inflammatory cells, facilitating lung tissue repair.
- This study redefines TNF's role from a mediator to a suppressor of pulmonary inflammation in this model.